Sentence examples for support cost effectiveness from inspiring English sources
There is limited evidence to support cost effectiveness of population screening in rheumatoid arthritis and case finding strategies have been proposed as a means to increase cost effectiveness of diagnostic screening for osteoporosis.
The collection of preference-based health outcomes data (or utility values) is required to support cost-effectiveness analyses.
Studies support cost-effectiveness of HHD when compared to ICHD.
Such reasoning has been used to support cost-effectiveness analyses of the TST and QFT for diagnosis of LTBI [ 36].
This is of less relevance when considering the use of these equations to support cost-effectiveness analyses because it is the incremental difference in event rates (typically driven by risk factors reported in randomized clinical trials) that is important.
Two studies support cost-effectiveness in ER+ populations, but in ER− patients and in a mixed (ER+, ER−) population, the clinical outcomes were poorer following MammaPrint testing than with usual care.
Whilst there is some evidence to support cost-effectiveness of screening and treating post menopausal women with rheumatoid arthritis who are starting corticosteroid treatment [ 13], the cost effectiveness of screening an unselected post-menopausal rheumatoid arthritis population has not been reported.
We performed a Markov model supported cost-effectiveness analysis to compare costs and QALYs of nab-paclitaxel and conventional paclitaxel in MBC patients.
There is insufficient evidence supporting cost-effectiveness or outcomes for recommending the utilization of gadoxetic acid-enhanced MRI for HCC screening at this time.
In general, we can propose several approaches for eradicating a malicious code incident in a cloud platform: It should be noted that in a highly distributed system such as a cloud environment, doing complicated tasks such as fixing a single infected node in real time fashion does not support the cost effectiveness policy.
Overall, the model supported the cost effectiveness of lenalidomide therapy compared with best supportive care (including EPO) when accounting for potential increases in quality of life.
